Tasly Pharmaceutical Group Co. Ltd. A | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,040
1,163
1,351
1,597
2,052
3,295
Total Accounts Receivable
3,368
5,004
6,578
7,232
10,355
11,606
Inventories
1,265
1,477
1,764
2,012
2,231
2,397
Other Current Assets
176
145
205
334
411
521
Total Current Assets
5,850
7,788
9,897
11,176
15,049
17,819
Net Property, Plant & Equipment
2,933
3,535
3,688
3,908
3,961
3,944
Total Investments and Advances
412
409
530
685
1,054
1,362
Long-Term Note Receivable
82
94
-
-
-
-
Intangible Assets
732
820
973
1,078
1,184
1,741
Other Assets
126
185
229
189
179
184
Total Assets
10,212
12,921
15,413
17,126
21,532
25,172
ST Debt & Current Portion LT Debt
2,849
4,812
4,497
5,522
8,157
Accounts Payable
887
1,322
1,447
1,857
2,067
Income Tax Payable
97
81
88
129
148
Other Current Liabilities
1,156
551
554
651
968
Total Current Liabilities
4,990
6,767
6,586
8,159
11,340
Long-Term Debt
871
814
800
401
893
Provision for Risks & Charges
-
-
11
24
-
Deferred Taxes
77
90
95
91
104
Other Liabilities
-
-
-
-
325
Total Liabilities
5,860
7,581
7,397
8,584
12,557
Common Equity (Total)
3,832
4,838
7,469
7,964
8,655
Total Shareholders' Equity
3,832
4,838
7,469
7,964
8,655
Total Equity
4,143
5,068
7,707
8,207
8,974
Liabilities & Shareholders' Equity
10,212
12,921
15,413
17,126
21,532
Accumulated Minority Interest
311
231
237
243
320
Non-Equity Reserves
208
272
309
336
-
About Tasly Pharmaceutical Group Co.
View Profile
